Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AMGN | REGN | VRTX | BMY |
| Company | Akero Therapeutics Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 26.52 | 326.27 | 1,195.72 | 482.39 | 47.67 |
| High | 27.82 | 331.29 | 1,202.24 | 486.77 | 48.24 |
| Low | 26.24 | 325.38 | 1,190.00 | 481.19 | 47.38 |
| Last | 27.46 | 328.80 | 1,199.12 | 481.24 | 48.11 |
| Change | +1.35 | +4.27 | +11.46 | +1.35 | +0.49 |
| % Change | +5.17% | +1.32% | +0.96% | +0.28% | +1.03% |
| Volume | 533,200 | 1,771,000 | 352,600 | 999,600 | 8,328,400 |
| 20-Day Average Volume | 501,760 | 2,023,340 | 490,735 | 1,232,055 | 14,019,645 |
| Previous Close | 26.11 | 324.53 | 1,187.66 | 479.89 | 47.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.41 | 326.68 | 1,130.58 | 481.19 | 48.15 |
| 20-Day Raw Stochastic | 84.46% | 64.75% | 97.30% | 44.11% | 38.03% |
| 20-Day Relative Strength | 58.58% | 53.91% | 72.12% | 51.57% | 57.13% |
| Weighted Alpha | +50.24 | +28.63 | +51.80 | +37.03 | -17.39 |
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 100% Buy | 56% Buy | 8% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.46% since 08/16/24 | +2.29% since 08/16/24 | +1.68% since 08/16/24 | +0.81% since 08/16/24 | -2.53% since 08/16/24 |
| Low | 24.45 on 08/19/24 | 321.41 on 08/19/24 | 1,178.18 on 08/19/24 | 476.00 on 08/19/24 | 46.88 on 08/22/24 |
| High | 27.82 on 08/23/24 | 331.29 on 08/23/24 | 1,203.49 on 08/21/24 | 491.88 on 08/21/24 | 49.99 on 08/19/24 |
| 1-Month | |||||
| %Chg | -1.19% since 07/23/24 | -1.33% since 07/23/24 | +13.60% since 07/23/24 | -1.85% since 07/23/24 | +11.94% since 07/23/24 |
| Low | 22.84 on 08/05/24 | 306.59 on 08/07/24 | 1,041.85 on 08/01/24 | 458.04 on 08/13/24 | 43.25 on 07/24/24 |
| High | 29.12 on 07/26/24 | 346.85 on 07/25/24 | 1,203.49 on 08/21/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 3-Month | |||||
| %Chg | +45.21% since 05/23/24 | +7.28% since 05/23/24 | +22.29% since 05/23/24 | +6.75% since 05/23/24 | +15.82% since 05/23/24 |
| Low | 17.86 on 06/05/24 | 295.30 on 06/13/24 | 952.30 on 05/30/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 |
| High | 29.12 on 07/26/24 | 346.85 on 07/25/24 | 1,203.49 on 08/21/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | +8.37% since 02/23/24 | +13.70% since 02/23/24 | +22.21% since 02/23/24 | +11.89% since 02/23/24 | -6.87% since 02/23/24 |
| Low | 17.86 on 06/05/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 37.00 on 03/04/24 | 346.85 on 07/25/24 | 1,203.49 on 08/21/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,898,886 | 176,379,824 | 132,126,224 | 124,185,432 | 97,523,776 |
| Shares Outstanding, K | 69,151 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -151,760,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -55,990,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | -0.28 | 0.58 | 0.13 | 0.39 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.81 on 08/09/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/09/24 | 08/06/24 | 08/01/24 | 08/01/24 | 07/26/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.45 | 30.91 | 0.00 | 34.76 |